Ulrika Wählby Hamrén, PhD

AstraZeneca, Gothenburg, Sweden
Mölndal, Vastra Gotaland, Sweden

AstraZeneca R&D (Employee, Shareholder)

Presentation(s):

• LB13 - The Efficacy and Impact in Heathy Infants of Nirsevimab on Medically Attended RSV Lower Respiratory Tract Infection

  Saturday, October 2, 2021
  1:15 PM - 3:00 PM EDT